FindTrial
Sign In

A prospective trial to determine if we can reduce the amount of vasopressor for prevention of hypotension caused by spinal anesthesia when ondansetron is administered before spinal anesthesia for cesarean section

The effect of ondansetron in reducing dose of vasopressor for preventing hypotension following spinal anesthesia for Cesarean delivery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0003609
Enrollment
142
Registered
2019-03-11
Start date
2019-03-04
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Bundang CHA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Singleton Korean patients between the age of 19 and 50 years of American Society Anesthesiologists (ASA) physical status II scheduled for elective caesarean section.

Exclusion criteria

Exclusion criteria: foreigner, QTc prolongation on electrocardiogram, contraindication to neuraxial block, BMI >45kg/m2, preexisting hypertension or pregnancy induced hypertension requiring treatment, placenta previa, abruptio, allergic to the medicine,gestational ages< 35 wks,intrauterine growth retardation, fetal distress, cardiac/renal or other end-organ disease,patients in active labor.

Design outcomes

Primary

MeasureTime frame
dose of infused phenylephrine during Cesarean delivery—

Secondary

MeasureTime frame
incidence of hypotension;incidence of bradycardia (<60 bpm);incidence of intraoperative nausea and vomiting;incidence of shivering—

Countries

Korea, Republic of

Contacts

Public ContactJiyoung Lee

Bundang CHA General Hospital

leejiyoung0616@gmail.com+82-31-780-1838

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026